Mario Ledda earned a Ph.D. in neuroscience in 2007 and has been a cellular and molecular biology senior researcher at the Institute of Translational Pharmacology (IFT-CNR) since 2008. In 2010, he obtained a research fellowship for a collaborative research project on cell-mediated delivery of anti-cancer therapeutics at the Joan C. Edwards School of Medicine, Marshall University, Huntington, West Virginia, USA. Dr. Mario Ledda is a highly experienced expert evaluator for national and European funding programmes. He holds interdisciplinary expertise at the interface of regenerative medicine, tissue engineering, smart biomaterials,biomedical technologies, nanotechnology and Artificial Intelligence for health. Furthermore, he brings high-level institutional experience, having served as Scientific Adviser to the Italian Minister for University and Research, where he contributed to strategic planning, research policy, and innovation ecosystem governance. Dr. Ledda regularly evaluates multidisciplinary and Deep Tech proposals for Horizon Europe (e.g., Pathfinder) and national ministries (MUR, MIMIT). In his evaluation panel roles, he focuses on comprehensive assessments encompassing scientific excellence, Proof of Concept (PoC) validation, technology readiness level (TRL) advancement, and Health Technology Assessment (HTA).